MedPath

Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process

Not Applicable
Recruiting
Conditions
Astigmatism
Registration Number
NCT06967129
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This is a prospective, multi-site, dispensing, randomized, controlled, double-masked, bilateral wear, 2x2 crossover study to evaluate the safety and effectiveness of the test lens.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
282
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Lens Rotational Stability with BlinksAt baseline per wear period

Rotational stability will be assessed for each eye at least 15 minutes after lens insertion. Lens rotational stability with blinks will be defined as a binary endpoint, the percentage of eyes that achieve rotational stability with blinks ≤ 5°.

Distance (4m) Monocular High Luminance High Contrast (HLHC) logMAR Visual Acuity (VA)At each 1-week follow-up per wear period

VA will be assessed monocularly under HLHC conditions at a test distance of 4 meters using ETDRS Charts.

Toric Lens OrientationAt baseline per wear period

Toric lens orientation (scribe mark position relative to 6 o'clock) will be assessed for each eye at 15 minutes after lens insertion. Toric lens orientation will be used to define a binary endpoint, i.e. the percentage of eyes that achieve absolute toric lens rotation ≤ 10°.

Percentage of eyes with Grade 3 or higher SLFs relating to the test lensUp to 3-week follow-up

SLFs (Grade 3 or higher) related to study lens wear for the test lens will be assessed for each eye at all study visits (scheduled and unscheduled). SLFs will be evaluated and graded using the FDA Grading scale from 0 to 4, where Grade 0 represents the absence of findings and 1 to 4 representing successively worse findings. The percentage of eyes with Grade 3 or higher SLF will be analyzed and will include corneal infiltrates.

Percentage of eyes with acceptable lens fitting while wearing the test lensUp to 3-week follow-up

Acceptable lens fit will be assessed at all study visits (scheduled and unscheduled) for each subject eye and used to define a binary endpoint, i.e. the percentage of eyes that achieve acceptable lens fit while wearing the test lens.

Lens fit will be deemed unacceptable if any one of the following criteria are met:

* limbal exposure at primary gaze or with extreme eye movement.

* edge lift.

* excessive movement on blink in primary gaze.

* insufficient movement in all three of the following conditions: primary gaze, up gaze, and push up test.

Secondary Outcome Measures
NameTimeMethod
Subjective Overall ComfortAt each 1-week follow-up per wear period

Subjective overall Comfort scores will be assessed using the CLUE questionnaire. CLUE™ is a validated, patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, for wearers between 18 to 65 years of age. CLUE™ scores are derived using Item Response Theory (IRT) and follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Subjective Overall Quality of VisionAt each 1-week follow-up per wear period

Subjective Overall Quality of Vision scores will be assessed using the CLUE questionnaire. CLUE™ is a validated, patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, for wearers between 18 to 65 years of age. CLUE™ scores are derived using Item Response Theory (IRT) and follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Subjective Overall HandlingAt each 1-week follow-up per wear period

Subjective Overall Handling scores will be assessed using the CLUE questionnaire. CLUE™ is a validated, patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, for wearers between 18 to 65 years of age. CLUE™ scores are derived using Item Response Theory (IRT) and follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Trial Locations

Locations (20)

James R. Dugue, Optometrist

🇺🇸

Mission Viejo, California, United States

Scripps Poway Eyecare & Optometry

🇺🇸

San Diego, California, United States

Stam & Associates Eye Care

🇺🇸

Jacksonville, Florida, United States

Omega Vision Center

🇺🇸

Longwood, Florida, United States

Maitland Vision Centers - North Orlando Ave

🇺🇸

Maitland, Florida, United States

Mid-State Eye

🇺🇸

Clinton, Illinois, United States

Franklin Park Eye Center, P.C.

🇺🇸

Franklin Park, Illinois, United States

Kannarr Eye Care - 101 North Broadway

🇺🇸

Pittsburg, Kansas, United States

Complete Eye Care of Medina

🇺🇸

Medina, Minnesota, United States

Advanced Eyecare - Raytown, MO

🇺🇸

Raytown, Missouri, United States

The Koetting Associates

🇺🇸

Saint Louis, Missouri, United States

ABQ Eye Care

🇺🇸

Albuquerque, New Mexico, United States

Spectrum Eye Care

🇺🇸

Jamestown, New York, United States

Sacco Eye Group

🇺🇸

Vestal, New York, United States

ProCare Vision Centers

🇺🇸

Granville, Ohio, United States

Professional Vision Care Inc. - Westerville

🇺🇸

Westerville, Ohio, United States

Optometry Group, PLLC

🇺🇸

Memphis, Tennessee, United States

Total Eye Care

🇺🇸

Memphis, Tennessee, United States

Tyler Eye Associates

🇺🇸

Tyler, Texas, United States

Clarke EyeCare Center

🇺🇸

Wichita Falls, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath